& Umetsu, D
What You Should Know About NAION Lawsuits Related to GLP-1 Use People taking glucagon-like peptide-1 (GLP-1) medications for diabetes or weight loss have experienced a significantly higher rate of the development of non-arteric ischemic optic neuropathy (NAION)
Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, et al
By adopting a proactive approach to monitoring and patient education, healthcare providers can maximize the therapeutic benefits of Semaglutide while minimizing its risks
Stromal cells covering omental fat-associated lymphoid clusters trigger formation of neutrophil aggregates to capture peritoneal contaminants
If material is not included in the articles Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder